Division of Gastroenterology, Department of Medicine, University of California, San Francisco, CA, USA.
Center for Gut Microbiota Research, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):656-661. doi: 10.1038/s41575-019-0204-0. Epub 2019 Sep 27.
Research into the gut microbiota and its role in health and disease has expanded rapidly in the past two decades. However, much of the early focus has been on cataloguing the microorganisms present, identifying correlations between microbial species and disease and using preclinical animal models to understand phenotypes. Now efforts are under way to provide functional insights into the gut microbiota and its mechanisms of action, improve understanding of the role of the microbiota beyond the gut and advance the development of microbiota-based therapeutics so that the microbiome can be harnessed in the clinic. In this Viewpoint article, we asked a selection of scientists and clinicians working in the gut microbiome field for their opinions on the major advances in and the challenges and solutions for translating gut microbiome research to the clinic, and where they expect progress to be made in the future.
在过去的二十年中,对肠道微生物组及其在健康和疾病中的作用的研究迅速发展。然而,早期的研究重点主要集中在对存在的微生物进行编目,确定微生物物种与疾病之间的相关性,并使用临床前动物模型来了解表型。现在,人们正在努力深入了解肠道微生物组及其作用机制,提高对肠道以外微生物组作用的认识,并推进基于微生物组的治疗方法的发展,以便在临床上利用微生物组。在这篇观点文章中,我们向从事肠道微生物组研究的一组科学家和临床医生询问了他们对将肠道微生物组研究转化为临床应用的主要进展、挑战和解决方案的看法,以及他们预计未来在哪些方面会取得进展。